The Quantellect read.As of Nov 19, 2026, 12 active firms cover Eastman Chemical Company: 5 rate it Buy or better, 7 sit at Neutral, and 0 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $65.00 to $80.00, so the covering firms are broadly aligned. The average target of $74.58 sits 20% above the current $62.34. The rating mix has stayed broadly stable, with Buy-side ratings easing from 7 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.40 next quarter toward $6.52 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 active firms
Neutral
Strong Buy00%
Buy542%
Neutral758%
Sell00%
Strong Sell00%
Based on 12 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$74.58
+19.6% upside
Average target across 12 active firms as of Nov 19, 2026 vs $62.34 current
Highest Target$80.00
Average Target$74.58
Lowest Target$65.00
Detailed analyst forecasts for EMN
Showing 1–12 of 12 named analysts shown · 12 active firms in the rating projection
As of Nov 19, 2026, 5 of 12 active firms rate EMN a Buy (7 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
EMN EPS & revenue forecast
EPS · NEXT QUARTER
$1.40
Range $1.17 – $1.53 · 7 analysts · +28% YoY
Next period, 7 analysts expect Eastman Chemical Company to earn $1.40 a share (range $1.17 – $1.53), versus $1.09 a year earlier. Full-year consensus is $6.11, growing to $6.52 the year after.
REVENUE · NEXT QUARTER
$2.3B
Range $2.2B – $2.4B · 7 analysts · +6% YoY
Revenue is expected to reach $2.3B (range $2.2B – $2.4B), +6.3% year-over-year. Full-year consensus is $9.2B, rising to $9.4B next year.
Top analysts covering Eastman Chemical Company
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EMN.
#1
Joshua Spector
UBS · Rank #56
Buy
$77.00+23.5% to target
Overall win rate
50%
+ Follow
#2
Michael Leithead
Barclays · Rank #61
Neutral
$85.00+36.3% to target
Overall win rate
57%
+ Follow
#3
AY
Aleksey Yefremov
Keybanc · Rank #75
Buy
No targeton EMN
Overall win rate
50%
+ Follow
#4
Jeffrey Zekauskas
JP Morgan · Rank #114
Buy
$82.00+31.5% to target
Overall win rate
51%
+ Follow
#5
John Roberts
Mizuho · Rank #125
Buy
$80.00+28.3% to target
Overall win rate
48%
+ Follow
EMN stock forecast FAQ
What is EMN's average 12-month price target?+
The 12 active firms with a live target average $74.58 for Eastman Chemical Company over the next 12 months, ranging from a $80.00 high to a $65.00 low, as of Nov 19, 2026.
Is EMN stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 12 active firms as of Nov 19, 2026, 5 rate it Buy or Strong Buy, 7 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for EMN?+
The Street-high target is $80.00 (Mizuho), and the Street-low is $65.00 (RBC Capital). The average of all 12 active-firm targets is $74.58.
How many active Wall Street firms cover EMN?+
12 active firms have a recognized rating on Eastman Chemical Company as of Nov 19, 2026, and 12 active firms carry a live 12-month price target.
Who is the most accurate analyst covering EMN?+
Among analysts who currently cover EMN, Joshua Spector of UBS has the strongest overall Quantellect track record (Rank #56). Their current call is Buy with a $77.00 target.
What is Eastman Chemical Company's projected EPS for next quarter?+
The consensus estimate is $1.40 per share (range $1.17 – $1.53) across 7 analysts. Full-year EPS is projected at $6.11, rising to $6.52 the following year.
How much revenue is Eastman Chemical Company expected to report next quarter?+
Consensus revenue is $2.3B (range $2.2B – $2.4B). Full-year revenue is projected at $9.2B, growing to $9.4B next year.
Have analysts been upgrading or downgrading EMN lately?+
As of Nov 19, 2026, 5 of 12 active firms rate EMN a Buy (7 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EMN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.